CRSP Stock Analysis: Buy, Sell, or Hold?
CRSP - CRISPR Therapeutics AG
$50.60
-0.04 (-0.07%)
▼
5d:
-16.74%
30d:
+0.73%
90d:
-7.72%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 03, 2026
19d
Smart Money Accumulation
None View Scanner →
Strength: 6.6/10
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CRSP this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRSP is down 16.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRSP is down 16.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $50.59, which is considered oversold relative to its 30-day fair value range of $50.74 to $57.41.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $51.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $84.70 (+67.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $51.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $84.70 (+67.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$50.74 -
$57.41
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 67.3% below Wall St target ($84.70)
- WARNING: Recommendation downgraded due to -16.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$50.74 -
$57.41
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$51.04
Resistance Level
$63.45
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.09
Wall Street Target
$84.70
(+67.3%)
Revenue Growth (YoY)
68.6%
Share & Embed Analysis
Last updated: July 14, 2026 1:00 PM ET
Data refreshes hourly during market hours. Next update: 2:00 PM
Data refreshes hourly during market hours. Next update: 2:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
James R Kasinger
SELL
3182 shares
2026-03-23
Samarth Kulkarni
SELL
10020 shares
2026-03-23
James R Kasinger
SELL
3450 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
